Literature DB >> 19805119

Impaired tumor growth, metastasis, angiogenesis and wound healing in annexin A1-null mice.

Ming Yi1, Jan E Schnitzer.   

Abstract

Despite 2 decades of research, no clear function for annexin A1 (AnxA1) has been established. Using AnxA1-KO mice, we show that tumor growth and metastasis are significantly decreased, whereas rodent survival and tumor necrosis are greatly increased when tumors grow in AnxA1-KO mice. Systems analysis of gene expression in these tumors specifically implicates 2 related vascular functions, angiogenesis and wound healing, in this impairment. Both tumor vascular development and wound healing are greatly retarded in KO tissues. Aortic ring assays reveal induced AnxA1 expression on sprouting endothelial cells of normal mice whereas KO aortas exhibit impaired endothelial cell sprouting that is rescued by adenoviral expression of AnxA1. Key differences in specific gene regulation may define new molecular pathways mediating angiogenesis, including a reset profile of pro- versus anti-angiogenic factors, apparently distinct for physiological versus pathological angiogenesis. These studies establish novel pro-angiogenic functions for AnxA1 in vascular endothelial cell sprouting, wound healing, and tumor growth and metastasis, thereby uncovering a new functional target for repairing damaged tissue and treating diseases such as cancer. They also provide critical new evidence that the tumor stroma and its microenvironment can greatly affect tumor progression and metastasis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19805119      PMCID: PMC2764877          DOI: 10.1073/pnas.0901324106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  PANTHER: a library of protein families and subfamilies indexed by function.

Authors:  Paul D Thomas; Michael J Campbell; Anish Kejariwal; Huaiyu Mi; Brian Karlak; Robin Daverman; Karen Diemer; Anushya Muruganujan; Apurva Narechania
Journal:  Genome Res       Date:  2003-09       Impact factor: 9.043

Review 2.  Metalloproteinase inhibitors: biological actions and therapeutic opportunities.

Authors:  Andrew H Baker; Dylan R Edwards; Gillian Murphy
Journal:  J Cell Sci       Date:  2002-10-01       Impact factor: 5.285

3.  Aberrant inflammation and resistance to glucocorticoids in annexin 1-/- mouse.

Authors:  Robert Hannon; Jamie D Croxtall; Steve J Getting; Fiorita Roviezzo; Simon Yona; Mark J Paul-Clark; Felicity N E Gavins; Mauro Perretti; John F Morris; Julia C Buckingham; Roderick J Flower
Journal:  FASEB J       Date:  2002-12-03       Impact factor: 5.191

4.  Rescue of the early vascular defects in Tek/Tie2 null mice reveals an essential survival function.

Authors:  N Jones; D Voskas; Z Master; R Sarao; J Jones; D J Dumont
Journal:  EMBO Rep       Date:  2001-05       Impact factor: 8.807

5.  Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate.

Authors:  M J Lee; S Thangada; K P Claffey; N Ancellin; C H Liu; M Kluk; M Volpi; R I Sha'afi; T Hla
Journal:  Cell       Date:  1999-10-29       Impact factor: 41.582

6.  Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability.

Authors:  D Fukumura; T Gohongi; A Kadambi; Y Izumi; J Ang; C O Yun; D G Buerk; P L Huang; R K Jain
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

Review 7.  The basic and clinical implications of ABC transporters, Y-box-binding protein-1 (YB-1) and angiogenesis-related factors in human malignancies.

Authors:  Michihiko Kuwano; Takeshi Uchiumi; Hiroshi Hayakawa; Mayumi Ono; Morimasa Wada; Hiroto Izumi; Kimitoshi Kohno
Journal:  Cancer Sci       Date:  2003-01       Impact factor: 6.716

8.  The angiogenic and lymphangiogenic factor vascular endothelial growth factor-D exhibits a paracrine mode of action in cancer.

Authors:  Marc G Achen; Richard A Williams; Megan E Baldwin; Patricia Lai; Sally Roufail; Kari Alitalo; Steven A Stacker
Journal:  Growth Factors       Date:  2002-06       Impact factor: 2.511

9.  TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism.

Authors:  Dong-Wan Seo; Hongmei Li; Liliana Guedez; Paul T Wingfield; Tere Diaz; Rita Salloum; Bei-yang Wei; William G Stetler-Stevenson
Journal:  Cell       Date:  2003-07-25       Impact factor: 41.582

Review 10.  The role of sphingosine kinase 1 in cancer: oncogene or non-oncogene addiction?

Authors:  Mathew Vadas; Pu Xia; Geoff McCaughan; Jennifer Gamble
Journal:  Biochim Biophys Acta       Date:  2008-06-27
View more
  44 in total

1.  TIMP-2 targets tumor-associated myeloid suppressor cells with effects in cancer immune dysfunction and angiogenesis.

Authors:  Liliana Guedez; Sandra Jensen-Taubman; Dimitra Bourboulia; Clifford J Kwityn; Beiyang Wei; John Caterina; William G Stetler-Stevenson
Journal:  J Immunother       Date:  2012-07       Impact factor: 4.456

2.  Annexin-1-mediated endothelial cell migration and angiogenesis are regulated by vascular endothelial growth factor (VEGF)-induced inhibition of miR-196a expression.

Authors:  Anne-Laure Pin; François Houle; Patrick Fournier; Maëva Guillonneau; Éric R Paquet; Martin J Simard; Isabelle Royal; Jacques Huot
Journal:  J Biol Chem       Date:  2012-07-06       Impact factor: 5.157

Review 3.  Harnessing systems biology approaches to engineer functional microvascular networks.

Authors:  Lauren S Sefcik; Jennifer L Wilson; Jason A Papin; Edward A Botchwey
Journal:  Tissue Eng Part B Rev       Date:  2010-06       Impact factor: 6.389

4.  Hypoxic cancer-associated fibroblasts increase NCBP2-AS2/HIAR to promote endothelial sprouting through enhanced VEGF signaling.

Authors:  Fernanda G Kugeratski; Samuel J Atkinson; Lisa J Neilson; Sergio Lilla; John R P Knight; Jens Serneels; Amelie Juin; Shehab Ismail; David M Bryant; Elke K Markert; Laura M Machesky; Massimiliano Mazzone; Owen J Sansom; Sara Zanivan
Journal:  Sci Signal       Date:  2019-02-05       Impact factor: 8.192

5.  In vivo proteomic imaging analysis of caveolae reveals pumping system to penetrate solid tumors.

Authors:  Phil Oh; Jacqueline E Testa; Per Borgstrom; Halina Witkiewicz; Yan Li; Jan E Schnitzer
Journal:  Nat Med       Date:  2014-08-17       Impact factor: 53.440

6.  Up-regulated Annexin A1 expression in gastrointestinal cancer is associated with cancer invasion and lymph node metastasis.

Authors:  Yu Sato; Kensuke Kumamoto; Katsuharu Saito; Hirokazu Okayama; Suguru Hayase; Yasuhide Kofunato; Koutaro Miyamoto; Izumi Nakamura; Shinji Ohki; Yoshihisa Koyama; Seiichi Takenoshita
Journal:  Exp Ther Med       Date:  2011-01-20       Impact factor: 2.447

7.  Characterization of annexin A1 glycan binding reveals binding to highly sulfated glycans with preference for highly sulfated heparan sulfate and heparin.

Authors:  T Horlacher; C Noti; J L de Paz; P Bindschädler; M-L Hecht; D F Smith; M N Fukuda; P H Seeberger
Journal:  Biochemistry       Date:  2011-03-03       Impact factor: 3.162

8.  Hypoxia regulates ANXA1 expression to support prostate cancer cell invasion and aggressiveness.

Authors:  Valentina Bizzarro; Raffaella Belvedere; Vincenzo Migliaro; Elena Romano; Luca Parente; Antonello Petrella
Journal:  Cell Adh Migr       Date:  2016-11-11       Impact factor: 3.405

Review 9.  In vivo animal models for studying brain metastasis: value and limitations.

Authors:  Inderjit Daphu; Terje Sundstrøm; Sindre Horn; Peter C Huszthy; Simone P Niclou; Per Ø Sakariassen; Heike Immervoll; Hrvoje Miletic; Rolf Bjerkvig; Frits Thorsen
Journal:  Clin Exp Metastasis       Date:  2013-01-16       Impact factor: 5.150

10.  Annexin A1 in primary tumors promotes melanoma dissemination.

Authors:  Zied Boudhraa; Fabien Rondepierre; Lemlih Ouchchane; Roselyne Kintossou; Anna Trzeciakiewicz; Frederic Franck; Jean Kanitakis; Bruno Labeille; Juliette Joubert-Zakeyh; Bernadette Bouchon; Jean Luc Perrot; Sandrine Mansard; Janine Papon; Pierre Dechelotte; Jean-Michel Chezal; Elisabeth Miot-Noirault; Mathilde Bonnet; Michel D'Incan; Françoise Degoul
Journal:  Clin Exp Metastasis       Date:  2014-07-06       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.